Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares

Bulletin Express

06/01

Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026.

• Transaction details – Volume repurchased: 174,400 H-shares, now held as treasury stock. – Price range: HKD 15.66 to HKD 16.54 per share, with a volume-weighted average of HKD 16.14. – Aggregate consideration: HKD 2.81 million.

• Capital structure impact – Issued shares outstanding (excluding treasury shares) decreased to 224.19 million from 224.36 million, a reduction of 0.08%. – Treasury shares rose to 2.88 million from 2.71 million. – Total issued shares remained unchanged at 227.07 million.

• Repurchase capacity – The current mandate authorises buybacks of up to 22.44 million shares; the latest transaction utilises 0.78% of that limit. – A 30-day moratorium on new share issues or treasury-share disposals runs through 1 July 2026, in line with HKEX Rule 10.06(3).

The company confirmed that the repurchase complied with Main Board requirements and that no material changes have been made to the explanatory statement filed on 8 May 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1100751279"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100751279\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100751279?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100751279","market":"us","top_or_hot":-1,"title":"Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026.</p>\n<p>• Transaction details  \n  – Volume repurchased: 174,400 H-shares, now held as treasury stock.  \n  – Price range: HKD 15.66 to HKD 16.54 per share, with a volume-weighted average of HKD 16.14.  \n  – Aggregate consideration: HKD 2.81 million.</p>\n<p>• Capital structure impact  \n  – Issued shares outstanding (excluding treasury shares) decreased to 224.19 million from 224.36 million, a reduction of 0.08%.  \n  – Treasury shares rose to 2.88 million from 2.71 million.  \n  – Total issued shares remained unchanged at 227.07 million.</p>\n<p>• Repurchase capacity  \n  – The current mandate authorises buybacks of up to 22.44 million shares; the latest transaction utilises 0.78% of that limit.  \n  – A 30-day moratorium on new share issues or treasury-share disposals runs through 1 July 2026, in line with HKEX Rule 10.06(3).</p>\n<p>The company confirmed that the repurchase complied with Main Board requirements and that no material changes have been made to the explanatory statement filed on 8 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-01 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026.</p>\n<p>• Transaction details  \n  – Volume repurchased: 174,400 H-shares, now held as treasury stock.  \n  – Price range: HKD 15.66 to HKD 16.54 per share, with a volume-weighted average of HKD 16.14.  \n  – Aggregate consideration: HKD 2.81 million.</p>\n<p>• Capital structure impact  \n  – Issued shares outstanding (excluding treasury shares) decreased to 224.19 million from 224.36 million, a reduction of 0.08%.  \n  – Treasury shares rose to 2.88 million from 2.71 million.  \n  – Total issued shares remained unchanged at 227.07 million.</p>\n<p>• Repurchase capacity  \n  – The current mandate authorises buybacks of up to 22.44 million shares; the latest transaction utilises 0.78% of that limit.  \n  – A 30-day moratorium on new share issues or treasury-share disposals runs through 1 July 2026, in line with HKEX Rule 10.06(3).</p>\n<p>The company confirmed that the repurchase complied with Main Board requirements and that no material changes have been made to the explanatory statement filed on 8 May 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1100751279","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100751279","pubTimestamp":1780321441,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026. • Transaction details...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics回购17.44万股H股，库存股扩大至288万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026.\n• Transaction details  \n  – Volume repurchased: 174,400 H-shares, now held as treasury stock.  \n  – Price range: HKD 15.66 to HKD 16.54 per share, with a volume-weighted average of HKD 16.14.  \n  – Aggregate consideration: HKD 2.81 million.\n• Capital structure impact  \n  – Issued shares outstanding (excluding treasury shares) decreased to 224.19 million from 224.36 million, a reduction of 0.08%.  \n  – Treasury shares rose to 2.88 million from 2.71 million.  \n  – Total issued shares remained unchanged at 227.07 million.\n• Repurchase capacity  \n  – The current mandate authorises buybacks of up to 22.44 million shares; the latest transaction utilises 0.78% of that limit.  \n  – A 30-day moratorium on new share issues or treasury-share disposals runs through 1 July 2026, in line with HKEX Rule 10.06(3).\nThe company confirmed that the repurchase complied with Main Board requirements and that no material changes have been made to the explanatory statement filed on 8 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}